Switching on the cell's energy sensor extended lifespan by over 25% in some cases — in yeast, worms and flies, not people
Edited by Samael A. Tejada, Founder & Editor-in-Chief
·Tip: press play, then lock your phone or switch apps — the article keeps reading.
Directly activating AMPK — the enzyme that senses low cellular energy and coordinates the mitochondrial response — with the research compound 991 extended lifespan in fission yeast, nematode worms and fruit flies, by more than 25% in some cases, and the effect vanished without functional AMPK (Aging Cell, September 2026). Higher doses sometimes shortened lifespan, mice showed molecular changes only, and 991 has never been given to a person.
Every longevity pathway eventually runs through the question of energy: how a cell knows it is running low, and what it does next. This study is the cleanest test yet of one specific answer — flip the fuel gauge itself, directly, and see whether life gets longer.
What is AMPK, and why do longevity researchers care?
AMP-activated protein kinase (AMPK) is an ancient, evolutionarily conserved sensor of energy homeostasis. When cellular energy falls, AMPK activates: it promotes energy-producing processes — including mitochondrial biogenesis, the making of new mitochondria — and restrains energy-consuming growth signalling such as mTOR. Indirect activators like metformin touch AMPK among many other targets, so lifespan results with those drugs cannot isolate AMPK's own contribution. Compound 991 is different: it binds directly at the interface of AMPK's subunits and switches the enzyme on, letting the researchers test AMPK activation as the sole variable.
What did the lifespan experiments show?
991 extended lifespan in all three test organisms: fission yeast (Schizosaccharomyces pombe), the roundworm Caenorhabditis elegans, and the fruit fly Drosophila melanogaster — in some cases by more than 25%, per the MRC Laboratory of Medical Sciences summary of the paper. The decisive control: in worms and yeast genetically lacking functional AMPK, the lifespan-extending effect was abolished. That on/off pattern is what separates a pathway result from a drug coincidence. The dose-response was not linear — higher doses of 991 shortened lifespan in some experiments, a finding the coverage of the study has consistently flagged.
What happened in mice — and what does this mean for people?
Mice received 991 for three weeks, for protein analysis rather than a lifespan test. Their liver proteome shifted in a pro-longevity direction consistent with AMPK activation — increased processes associated with ATP production and mitochondrial biogenesis, alongside suppression of mTOR signalling. The researchers stress that this demonstrates no lifespan extension in mammals; a long-term mouse lifespan study is the stated next step. For readers: 991 is an experimental research compound that has never been administered to humans, no supplement sold as an 'AMPK activator' reproduces this experiment, and the one intervention already known to activate AMPK in human muscle is exercise. This is proof-of-principle for a drug target — genuinely important, and years from a therapy.
Frequently asked questions
What is AMPK?
AMPK (AMP-activated protein kinase) is an enzyme found across species that senses low cellular energy. When it activates, it promotes energy production — including the making of new mitochondria — and restrains growth signalling through mTOR.
Did the AMPK drug extend lifespan in mice or people?
No. Lifespan extension was shown in fission yeast, nematode worms and fruit flies. Mice were treated for three weeks for protein analysis only and showed molecular changes consistent with AMPK activation; no mouse lifespan result exists, and compound 991 has never been given to a human.
Can a supplement activate AMPK the same way?
No supplement has been shown to reproduce direct AMPK activation by compound 991 or to extend human lifespan. Higher doses of 991 itself shortened lifespan in some experiments. Exercise is the intervention known to activate AMPK in human muscle.
Where the evidence stands
- Established: AMPK is a conserved cellular energy sensor that regulates mitochondrial biogenesis and mTOR signalling; exercise activates AMPK in human muscle.
- Preliminary: Direct AMPK activation extending lifespan: demonstrated in yeast, worms and flies in one Aging Cell study (2026), with the AMPK-deficient control abolishing the effect; mouse data are a three-week proteomic profile only, with no lifespan endpoint.
- Absent: Any human evidence. Compound 991 has never been given to a person, and no marketed supplement has been shown to reproduce direct AMPK activation or extend human lifespan.
Join the discussion
To get the conversation started: What questions does this story raise for you? Share them below — every comment is reviewed by our moderators before it appears.
Community discussion only — not medical advice. Every comment is reviewed by our moderators before it appears. Sign in with Google or a free Hyvor account to join in.